Apnimed Inc (APMD)

Currency in USD
18.99
+0.46(+2.48%)
Closed·
18.990.00(0.00%)
·
APMD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
17.8419.15
52 wk Range
16.0035.29
Key Statistics
Prev. Close
18.99
Open
18.5
Day's Range
17.84-19.15
52 wk Range
16-35.29
Volume
277.3K
Average Volume (3m)
511.68K
1-Year Change
-
Book Value / Share
NA
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
APMD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
50.33
Upside
+165.05%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Apnimed Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 50.33
(+165.05% Upside)

Earnings

Latest Release
08/09/2026
EPS / Forecast
3.92 / --
Revenue / Forecast
12.08M / --
EPS Revisions
Last 90 days

APMD Income Statement

Compare APMD to Peers and Sector

Metrics to compare
APMD
Peers
Sector
Relationship
P/E Ratio
4.6x−0.7x−0.3x
PEG Ratio
-−0.080.00
Price/Book
−4.5x2.0x2.6x
Price / LTM Sales
6.9x1.5x2.9x
Upside (Analyst Target)
165.1%59.7%65.5%
Fair Value Upside
Unlock20.6%9.5%Unlock

Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. It offers AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
9.07M21.78%172.17M
Other Institutional Investors
27.65M66.42%525.13M
Public Companies & Retail Investors
4.91M11.80%93.27M
Total
41.63M100.00%790.57M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Columbia Management Investment Advisers, LLC17.96%7,476,992141,988
Columbia Funds Series Trust II - Columbia Seligman Technology and Information Fund17.88%7,443,633141,355

People Also Watch

15.41
SCTX
-14.25%
12.80
KARD
+0.47%
21.44
BRVE
-0.19%
5.56
PSQL
-1.59%
15.02
LTGO
-9.35%

FAQ

What Is the Apnimed (APMD) Stock Price Today?

The Apnimed stock price today is 18.99 USD.

What Stock Exchange Does Apnimed Trade On?

Apnimed is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Apnimed?

The stock symbol for Apnimed is "APMD."

What Is the Apnimed Market Cap?

As of today, Apnimed market cap is 771.42M USD.

What Is Apnimed's Earnings Per Share (TTM)?

The Apnimed EPS (TTM) is 31.51.

When Is the Next Apnimed Earnings Date?

Apnimed will release its next earnings report on 02/12/2026.

From a Technical Analysis Perspective, Is APMD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Apnimed Stock Split?

Apnimed has split 0 times.

How Many Employees Does Apnimed Have?

Apnimed has 81 employees.

What is the current trading status of Apnimed (APMD)?

As of 24/10/2026, Apnimed (APMD) is trading at a price of 18.99 USD, with a previous close of 18.99 USD. The stock has fluctuated within a day range of 17.84 USD to 19.15 USD, while its 52-week range spans from 16.00 USD to 35.29 USD.

What Is Apnimed (APMD) Price Target According to Analysts?

The average 12-month price target for Apnimed is 50.33 USD, with a high estimate of 60 USD and a low estimate of 41 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +165.05% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.